戻る Agenda
S33 : Developing Talent in the Society 5.0 Era: Who are the Critical R&D Personnel for Open Innovation?
Session Chair(s)
Fumitaka Noji
Asscociate Director, Clinical Operations (Therapeutics and Oncology)
Moderna Japan Co., Ltd., Japan
Speaker(s)
Policies and Programs on University Startups
Kenkichi Sakoda
Ministry of Education, Culture, Sports, Science and Technology, Japan
Pharma’s Expectations vs. Reality Gap in Academia
Takeshi Kono
Nippon Boehringer Ingelheim, Co. Ltd./Kobe Pharma Research Institute, Japan
Licensing Manager, Business Development & Licensing
Tomoyoshi Koyanagi, PhD
iACT, Kyoto University Hospital, Japan
Propgram-Specific Professor , Director of Business Development,
International cooperation Through Translation Together
Mitsuo Satoh
Japan Agency for Medical Research and Development (AMED), Japan
Senior Science Coordinator, Division of Strategic Planning and Evaluation
Makoto Nagaoka, PhD
BeiGene Japan, Japan
Head of Regulatory Affairs, Japan